Protein-mediated fatty acid uptake in the heart

Current Cardiology Reviews

Volumn 4, Issue 1, 2008, Pages 12-21

  Chabowski, Adrian ^a   Górski, Jan ^a   Glatz, Jan F C ^b   Luiken, Joost J F P ^b   Bonen, Arend ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

FABPpm; FAT CD36; Fatty acid transport; Heart

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; CD36 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIAZEPAM BINDING INHIBITOR; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 1; GLUCOSE; INSULIN; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 3;

CARDIOMYOPATHY; DIABETES MELLITUS; ENZYME ACTIVATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE MUTATION; GLUCOSE UTILIZATION; HEART CONTRACTION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HORMONAL REGULATION; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION;

EID: 48249092099     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340308783565429     Document Type: Review

References (103)

1. van der Vusse GJ, Glatz JFC, Stam HCG, Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992; 72: 881.
2. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85(3): 1093-129.
3. Glatz J, van der Vusse GJ. Fatty acids in cell signalling: modulation by lipid binding proteins. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 121-127.
4. Bonen A, Chabowski A, Luiken JJ, Glatz JF. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) 2007; 22: 15-29.
5. Hamilton JA, Kamp F. How arc free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 1999; 48: 2255-2269.
6. Kamp F, Hamilton JA. How fatty acids of different chain length enter and leave cells by free diffusion. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 149-59.
7. Hamilton JA, Guo W, Kamp F. Mechanism of cellular uptake of long-chain fatty acids: do we need cellular proteins? Mol Cell Biochem. 2002; 239(1-2): 17-23.
8. Kampf JP, Kleinfeld AM. Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda) 2007; 22: 7-14.
9. Coort SL, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem. 2006 DOI: 10.1007/ s11010-005-9030-5.
10. Koonen DP, Glatz JF, Bonen A, Luiken JJ. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta. 2005; 1736(3): 163-80.
11. Chabowski A, Gorski J, Bonen A. Regulation of fatty acid transport: from transcriptional to posttranscriptional effects. Naunyn-Schmiedeberg's Arch Pharmacol 2006; 373: 259-263.
12. Chabowski A, Coort SL, Calles-Escandon J, et al. Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am J Physiol Endocrinol Metab 2004; 287(4): E781-9.
13. Chabowski A, Court SL, Calles-Escandon J, et al. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett 2005; 579(11): 2428-32.
14. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 1998; 95: 8625-8629.
15. Luiken JJ, Koonen DPY, Willems J, et al. Insulin stimulates long-chain fatty acid uilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 2002; 51: 3113-3
16. Luiken JJ, Coort SL, Willems J, et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003; 52(7): 1627-34.
17. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 2000; 275(42): 32523-9.
18. Irie H, Krukenkamp IB, Brinkmann JF, et al. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci USA 2003; 100(11): 6819-24.
19. Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation 2004; 109(12): 1550-7.
20. Clarke DC, Miskovic D, Han XX, et al. Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol Genomics 2004; 17(1): 31-7.
21. Chiu HC, Kovacs A, Blanton RM, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005; 96(2): 225-33.
22. Wu Q, Ortegon AM, Tsang B, et al. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 2006; 26: 3455-3467.
23. Kim JK, Gimeno, RE, Higashimori T, et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 2004; 113: 756-763.
24. DiRusso CC, Li H, Darwis D, Watkins PA, Berger J, Black PN. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J Biol Chem 2005; 280: 16829-16837.
25. Gimeno RE, Ortegon AM, Patel S, et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003; 278(18): 16039-44.
26. Glatz JF, Bonen A, Ouwens DM, Luiken JJ. Regulation of sarcolemmal transport of substrates in the healthy and diseased heart. Cardiovasc Drugs Ther 2006; 20(6): 471-6.
27. Luiken JJ, Turcotte LP, Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 1999; 40(6): 1007-16.
28. Habets DD, Coumans WA, Voshol PJ, et al. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem Biophys Res Commun 2007; 355(1): 204-10.
29. Ibrahimi A, Sfeir Z, Magharaine H, Amri EZ, Grimaldi P, Abumrad NA. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc Natl Acad Sci USA 1996; 93: 2646-2651.
30. Isola LM, Zhou SL, Kiang CL, Stump DD, Bradbury MW, Berk PD. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci USA 1995; 92: 9866-9870.
31. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994; 79: 427-
32. Schaap FG, van der Vusse GJ, Glatz JF. Evolution of the family of intracellular lipid binding proteins in vertebrates. Mol Cell Biochem 2002; 239(1-2): 69-77.
33. Londraville RL. Intracellular fatty acid-binding proteins: putting lower vertebrates in perspective. Braz J Med Biol Res 1996; 29(6): 707-20.
34. Spitsberg VL, Matitashvili E, Gorewit RC. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur J Biochem 1995; 230(3): 872-8.
35. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 1999; 13(8): 805-12.
36. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, Glatz JF. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 1999; 85(4): 329-37
37. Luiken JJ, Koonen DP, Coumans WA, et al. Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice. Lipids 2003; 38(4): 491-6.
38. Binas B, Han XX, Eroll E, et al. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am J Physiol Endocrinol Metab 2003: 285: E481-E
39. Bonen A, Luiken JJFP, Lui S, et al. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 1998; 275: E471-E
40. Tong F, Black PN, Coleman RA, DiRusso CC. Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases. Arch Biochem Biophys 2006; 447(1): 46-52.
41. Black PN, Dirusso CC. Yeast acyl-CoA synthetases at the crossroads of fatty acid metabolism and regulation. Biochim Biophys Acta 2006; PMID: 16798075.
42. Stremmel W, Pohl L, Ring A, Herrmann T. A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 2001; 36(9): 981-9.
43. Pohl J, Ring A, Ehehalt R, Herrmann T, Stremmel W. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc Nutr Soc 2004; 63 (2): 259-62.
44. Schaffer JE. Fatty acid transport: the roads taken. Am J Physiol Endocrinol Metab 2002; 282(2): E239-46.
45. Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J Lipid Res 1999; 40(5): 881-92.
46. Faergeman NJ, Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem J 1997; 323(Pt 1): 1-12.
47. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 2004; 279(35): 36235-41.
48. Bezaire V, Bruce CR, Heigenhauser GJ, et al. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab 2006; 290: E509-E515.
49. Holloway GP, Bezaire V, Heigenhauser GJ, et al. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase 1 activity in human skeletal muscle during aerobic exercise. J Physiol 2006; 571: 201-210.
50. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339-
51. Atkinson LL, Fischer MA, Lopaschuk GD. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem 2002; 277(33): 29424-30.
52. Rose AJ, Michell BJ, Kemp BE, Hargreaves M. Effect of exercise on protein kinase C activity and localization in human skeletal muscle. J Physiol 2004; 561(3): 861-70.
53. Kramer HF, Goodyear LJ. Exercise, MAPK, and NF-{kappa}B Signaling in Skeletal Muscle. J Appl Physiol. 2007; doi: 10.1152/ japplphysiol.00085.2007.
54. Chabowski A, Momken I, Coort SL, et al. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol Cell Biochem 2006; 288(1-2): 201-12.
55. Luiken JJ, Willems J, Coort SL, et al. Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. Biochem J 2002; 367(3): 881-7.
56. Luiken JJ, Momken I, Habets DD, et al. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling. Endocrinology. 2006; 147(11): 5205-16.
57. Scheuer J, Brachfeld N. Myocardial uptake and fractional distribution of palmitate-1 C14 by the ischemic dog heart. Metabolism 1966; 15(10): 945-54.
58. van der Vusse GJ, Roemen TH, Prinzen FW, Coumans WA, Reneman RS. Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ Res 1982; 50(4): 538-46.
59. Chabowski A, Gorski J, Calles-Escandon J, Tandon NN, Bonen A. Hypoxia-induced fatty acid transporter translocation increases fatty acid transport and contributes to lipid accumulation in the heart. FEBS Lett 2006; 580(15): 3617-23.
60. Mehrhof FB, Muller FU, Bergmann MW, et al. In cardiomyocyte hypoxia, insulin-like growth factor-1-induced antiapoptotie signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation 2001; 104(17): 2088-94.
61. Tripp ME. Developmental cardiac metabolism in health and disease. Pediatr Cardiol 1989; 10(3): 150-8.
62. Heather LC, Cole MA, Lygate CA, et al. Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc Res 2006; 72(3): 430-7.
63. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005; 1734: 112-126.
64. Scheuermann-Freestone M, Madsen PL, Manners D, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003; 107(24): 3040-6.
65. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997; 34(1): 25-33.
66. Dimitrakoudis D, Vranic M, Klip A. Effects of hyperglycemia on glucose transporters of the muscle: use of the renal glucose reabsorption inhibitor phlorizin to control glycemia. J Am Soc Nephrol 1992; 3(5): 1078-91.
67. Klip A, Tsakiridis T, Marette A, Ortiz PA. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 1994; 8(1): 43-53.
68. Tunstall RJ, Cameron-Smith D. Effect of elevated lipid concentrations on human skeletal muscle gene expression. Metabolism 2005; 54(7): 952-9.
69. Vettor R. Fabris R, Serra R, et al. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle. Int J Obes Relat Metab Disord. 2002; 26(6): 838-47.
70. Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 2000; 10: 238-245.
71. Finck BN. The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart. Curr. Opin. Clin. Nutr. Metab. Care 2004; 7: 391-396.
72. Cameron-Smith D, Burke LM, Angus DJ, et al. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am J Clin Nutr 2003; 77(2): 313-8.
73. van der Lee KA, Vork MM, De Vries JE, et al. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 2000; 41(1): 41-7.
74. Chabowski A, Chatham JC, Tandon NN, et al. Fatty Acid Transport and FAT/CD36 are increased in red but not in white skeletal muscle of Zucker Diabetic Fatty (ZDF) Rats. Am J Physiol Endocrinol Metab, 2006; 291(3): E675-82.
75. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 2000; 279(5): E1104-13.
76. Mazumder PK, O'Neill BT, Roberts MW, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004; 53(9): 2366-74.
77. Buchanan J, Mazumder PK, Hu P, et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005; 146(12): 5341-9.
78. Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000 Feb 15; 97(4): 1784-9.
79. Depre C, Young ME, Ying J, et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 2000; 32(6): 985-96.
80. Cbiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001; 107(7): 813-22.
81. Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 1989; 65(2): 378-87.
82. Hutter JF, Soboll S. Role of fatty acid metabolites in the development of myocardial ischemic damage. Int J Biochem 1992; 24(3): 399-403.
83. Luo J, Quart J, Tsai J, et al. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 1998; 47: 663-
84. Petro AE, Cotter J, Cooper DA, et al. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 2004; 53: 454-457.
85. Wang P, Lloyd SG, Zeng H, et al. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker Diabetic Fatty rats. Am J Physiol Heart Circ Physiol 2005; 288: H2102-H2110.
86. Lee Y, Wang MY, Kakuma T, et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001; 276: 5629-5635.
87. Finck B. The cardiac phenotype induced by PPAR overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002; 109: 121-130.
88. Finck B, Han X, Courtois M, et al. A critical role for PPARalpha- mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 200; 100: 1226-1231.
89. Yang J, Sambandam N, Han X, et al. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 2007; 100(8): 1208-17.
90. Coort SL, Hasselbaink DM, Koonen DP, et al. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes 2004; 53(7): 1655-63.
91. Luiken JJ, Arumugam Y, Bell RC, et al. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab 2002; 282: 612-62.
92. Carley AN, Atkinson LA, Bonen A, et al. Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 db/db mice. Arch Physiol Biochem 2007; 113: 65-75.
93. Chen M, Yang YK, Loux TJ, et al. The role of hyperglycemia in FAT/ CD36 expression and function. Pediatr Surg Int 2006; 22(8): 647-54.
94. Griffin E, Re A, Hamel N, et al. A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat Med 2001; 7(7): 840-6.
95. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997; 29(1): 121-7.
96. Hirooka K, Yasumura Y, Ishida Y, et al. Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency. Jpn Circ J 2000; 64(9): 731-5.
97. Lepretre F, Vasseur F, Vaxillaire M, et al. A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes. Hum Mutat 2004; 24(1): 104.
98. Tanaka T, Nakata T, Oka T, et al. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J Lipid Res 2001; 42(5): 751-9.
99. Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997; 29(1): 121-7.
100. Yoshizumi T, Nozaki S, Fukuchi K, et al. Pharmacokinetics and metabolism of 1231-BMIPP fatty acid analog in healthy and CD36- deficient subjects. J Nucl Med 2000; 41(7): 1134-8.
101. Yamashita S, Hirano K, Kuwasako T, et al. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol Cell Biochem 2007; 299: 19-22.
102. Ma X, Bacci S, Mlynarski W, et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004; 13(19): 2197-205.
103. Luiken JJ, Arumugam Y, Dyck DJ, et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 2001; 276(44): 40567-73.